In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. - Lass-Flörl,C.; Kofler,G.; Kropshofer,G.; Hermans,J.; Kreczy,A.; Dierich,M.P.; Niederwieser,D. (J Antimicrobial Chemother, 1998)